Patents by Inventor John R. Fozard

John R. Fozard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Medicament compositions derived from quinolizine and quinolizinone and methods of use thereof
    Patent number: 5011846
    Abstract: The present invention is directed to the use of esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one and hexahydro-8-hydroxy-2,6-methano-2H-quinolizines in the manufacture of a medicament for the treatment of anxiety, psychosis, glaucoma and for the stimulation of gastric motility.
    Type: Grant
    Filed: May 16, 1990
    Date of Patent: April 30, 1991
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Maurice W. Gittos, Francis P. Miller, Stephen M. Sorensen, John R. Fozard, Paul Moser, Michael G. Palfreyman, Hsien Cheng
  • Treatment of migraine with substituted tropyl benzoate derivatives
    Patent number: 4585866
    Abstract: Migraine is treated with a tropyl benzoate derivative of the following general formula: ##STR1## wherein: R.sub.1 represents C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy or halogen;R.sub.2 represents hydrogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy or halogen; andR.sub.3 represents hydrogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy or halogen, provided that R.sub.3 is hydrogen when R.sub.2 is hydrogen, or a pharmaceutically acceptable salt thereof.Additionally, some novel tropyl benzoate derivatives are disclosed.
    Type: Grant
    Filed: December 13, 1984
    Date of Patent: April 29, 1986
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: John R. Fozard, Maurice W. Gittos
  • Treatment of migraine with substituted tropyl benzoate derivatives
    Patent number: 4563465
    Abstract: Migraine is treated with a tropyl benzoate derivative of the following general formula: ##STR1## wherein: R.sub.1 represents C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy or halogen;R.sub.2 represents hydrogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy or halogen; andR.sub.3 represents hydrogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy or halogen, provided that R.sub.3 is hydrogen when R.sub.2 is hydrogen, or a pharmaceutically acceptable salt thereof.Additionally, some novel tropyl benzoate derivatives are disclosed.
    Type: Grant
    Filed: December 13, 1984
    Date of Patent: January 7, 1986
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: John R. Fozard, Maurice W. Gittos
  • Pseudotropyl halogeno-benzoates and their use in migraine treatment
    Patent number: 4486441
    Abstract: Migraine is treated with a novel pseudotropyl benzoate derivative of the following general Formula I: ##STR1## wherein: R.sub.1 represents halogen, preferably chlorine;R.sub.2 represents hydrogen or halogen, preferably chlorine; andR.sub.3 represents hydrogen or halogen, preferably chlorine, provided that R.sub.3 is hydrogen when R.sub.2 is hydrogen.
    Type: Grant
    Filed: December 8, 1982
    Date of Patent: December 4, 1984
    Assignee: Merrell Toraude Et Compagnie
    Inventors: John R. Fozard, Maurice W. Gittos